Filing Flows › Embecta (EMBC) › Next earnings date
Embecta (EMBC) earnings on Nov 25, 2026: what to expect
Embecta (EMBC) is expected to report earnings on Nov 25, 2026 (estimated), in 17 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of $0.29 ($0.28 to $0.31, 4 estimates) on revenue of $270M, against $0.50 and $263M a year ago. It beat the EPS estimate in 75% of the quarters on record; Filing Flows' model gives it a 76% chance of beating next time.
What to watch
Last quarter (Q3 FY26) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS $0.26 on revenue of $240M, against the analysts' $0.29.
The last report
Embecta reported revenue of $272M for the third quarter fiscal 2026 (-8% Y/Y), net earnings $21.1M: Pen Needles $178M, Safety $36.7M, Syringes $36.6M, Other $15.6M. How it makes money → · Every quarter →
Embecta's latest quarter
Embecta, Q3 FY26: revenue $272M (-8% year over year), operating margin 17.9%, net earnings $21.1M, operating cash flow $41.8M. The chart follows the revenue to costs, profit and cash.
Questions
When does EMBC report earnings?
Embecta is expected to report on Nov 25, 2026 (estimated).
What are analysts expecting from Embecta?
EPS of $0.29 and revenue of $270M for the quarter.
Does Embecta usually beat earnings?
It beat the consensus EPS estimate in 75% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.